Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q
Clinical trial NCT01081431 · COMPLETED
Trial details
- NCT number
- NCT01081431
- Sponsor
- Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-26
- Primary completion
- 2018-05-24
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.